Tech Company Financing Transactions
Emboline Funding Round
Emboline closed a $10 million Series B funding round on 4/24/2018. Investors included Shangbay Capital, SV Tech Ventures and private investors.
Transaction Overview
Company Name
Announced On
4/24/2018
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors
Shangbay Capital (Lead Investor) (William Dai)
SV Tech Ventures (Lead Investor) (Peng Cheng)
Proceeds Purpose
The working capital will be used to fund the SafePass Clinical trial for the Emboliner Embolic Protection Catheter, the subsequent European CE Mark submission and initial commercial launch.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2811 Mission St.
Santa Cruz, CA 95060
USA
Santa Cruz, CA 95060
USA
Phone
Website
Email Address
Overview
Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair and replacement procedures and other cardiovascular procedures with embolic risks.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Russell
Chief Technical Officer
Amir Belson
VP - R & D
Stephen Kleshinski
Browse more venture capital transactions:
Prev: 4/24/2018: Morf3D venture capital transaction
Next: 4/24/2018: Formlabs venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs